Aminopyridine derivatives and their use as selective ALK-2 inhibitors
US10710980B2 · kind B2 · utility
4Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 2017 |
| Grant date | Jul 14, 2020 |
| Priority date | — |
| Expiry date | Jul 18, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form (I) to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.